Feng Hong, based in Newbury Park, California, United States, is currently a Senior Director, Clinical Biomarker Operations at Turning Point Therapeutics, bringing experience from previous roles at BioMarin Pharmaceutical Inc.. Feng Hong holds a Ph.D. in Environmental Science @ University of Cincinnati. With a robust skill set that includes Sop, FDA, HPLC, Microbiology, UV/Vis and more, Feng Hong contributes valuable insights to the industry. Feng Hong has 3 emails and 1 mobile phone number on RocketReach.